Industry Reports

AbbVie announced patent license agreements with Mylan over its proposed biosimilar adalimumab product. Under the terms of the agreements, AbbVie will grant Mylan a non-exclusive license…
Read More...

GSK announced that Dermavant Sciences, a subsidiary of Roivant Sciences, has agreed to purchase the rights to tapinarof, an investigational therapeutic aryl hydrocarbon receptor…
Read More...

UL announced that together with Applied DNA Sciences Inc. they have joined forces to form a strategic partnership that will lay the foundation for a significant new development in…
Read More...

Otsuka Pharmaceutical and Visterra announce that they have entered into a definitive merger agreement pursuant to which Otsuka will acquire Visterra for approximately USD 430 million in…
Read More...

CURE Pharmaceutical announced that it has signed a term sheet with Therapix Biosciences to acquire the non-pain assets of Therapix, subject to the completion of the related conditions.…
Read More...

BioCryst Pharmaceuticals announced that it has terminated the previously announced merger agreement with Idera Pharmaceuticals following the BioCryst stockholders’ failure to approve…
Read More...

BioIVT announced that it has acquired Santa Clara, CA-based Optivia Biotechnology and its comprehensive portfolio of transporter assays, multi-transporter models, transporter systems…
Read More...

Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer and other diseases, today announced the…
Read More...

Juniper Pharmaceuticals announced that it has entered into a definitive agreement with Catalent, Inc. for Catalent to acquire all of the outstanding shares of Juniper at a price of…
Read More...

Akebia Therapeutics and Keryx Biopharmaceuticals announced that the companies signed, and the boards of directors of both companies have unanimously approved, a definitive merger…
Read More...

Starpharma and Mundipharma today announced they have signed a licence agreement for the sales and marketing rights to VivaGel BV for 43 countries in Europe, Russia, the Commonwealth of…
Read More...

Neptune Technologies & Bioressources Inc., announced that it entered into a multi-year agreement with Canopy Growth. Under the terms of the agreement, Neptune will supplement Canopy…
Read More...

BioMarin Pharmaceutical Inc. announced that the Company received $20 million in milestone payments from Pfizer Inc. These milestone payments were triggered by the U.S. Food and Drug…
Read More...

Blueprint Medicines Corporation and CStone Pharmaceuticals announced an exclusive collaboration and license agreement for the development and commercialization of avapritinib, BLU-554…
Read More...

Biogen announced that it has entered into an exclusive option agreement with TMS Co., Ltd. to acquire TMS-007 and backup compounds. The agreement includes an upfront payment of $4…
Read More...

Alcami Corporation announced that it has reached an agreement to be acquired by Madison Dearborn Partners. MDP will acquire a majority ownership position in Alcami from existing…
Read More...

Beactica announced that it has signed a three-year extension of its master services agreement with Sanofi. The agreement outlines the legal terms under which Beactica and Sanofi…
Read More...

Bicycle Therapeutics announced that it is expanding its collaboration with AstraZeneca to include additional targets in respiratory and cardio-metabolic diseases. The original…
Read More...

Pharmaceutical Product Development, LLC (PPD), and its real-world research and market access business unit, Evidera, have joined the Massachusetts Institute of Technology Center for…
Read More...

ViiV Healthcare, the global specialist HIV company, majority owned by GlaxoSmithKline, with Pfizer Inc. and Shionogi Limited as shareholders, announced that the European Commission has…
Read More...